What We Do

The Aplastic Anemia & Myelodysplasia Association of Canada (AAMAC) is a leading funder of research into bone marrow failure diseases in Canada. Our volunteer-run organization supports patients and caregivers across the country who are living with aplastic anemia, myelodysplastic syndrome (also called MDS or myelodysplasia) and paroxysmal nocturnal hemoglobinuria (PNH).

Mission

To provide a seamless support network for every Canadian patient, family member, friend, and concerned healthcare provider dealing with aplastic anemia, myelodysplasia and paroxysmal nocturnal hemoglobinuria.

Vision

To support all Canadians and their families and friends through diagnosis, treatment and remission stages of these diseases.

Latest News

AAMAC Patient and Caregiver Survey

AAMAC is developing a submission for the pan-Canadian Oncology Drug Review (pCODR) for (orally administered/tabl...

AAMAC Webinar Survey

Today’s climate—driven by precautions due to COVID-19 means AAMAC will not be hosting any in-person meetings for...

MDS Caregiver Research Opportunity

Dear member, An online research project is being planned for July 2020 to gather feedback from caregivers of ...

Coronavirus disease (COVID-19): UPDATE

Office Closure AAMAC has been closely monitoring the Coronavirus (COVID-19) outbreak and continues to observe H...